Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis
Defining the Mechanisms Underlying Adrenal Dysfunction in Cirrhosis and Its Prognostic Significance
Sponsor: American Association for the Study of Liver Diseases
Listed as NCT04642391, this observational or N/A phase trial focuses on Adrenal Insufficiency and Cirrhosis and remains completed. Sponsored by American Association for the Study of Liver Diseases, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jan 2025 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Not Yet Recruiting → Active Not Recruiting
-
Jan 2021 — Jan 2024 [monthly]
Not Yet Recruiting
▶ Show 1 earlier version
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- American Association for the Study of Liver Diseases
- University of Virginia
For direct contact, visit the study record on ClinicalTrials.gov .